Bonney Michael W (CIK 0001219016)

Latest company ownership

Shares held
9,189
Last filed at
Jun 9, 2020
Confidence Score
50.0
2025Q4
Confidence Score History
2019Q4 2025Q4
Shares held
4,000
Last filed at
Mar 10, 2016
Confidence Score
40.2
2025Q4
Confidence Score History
2015Q2 2025Q4
Shares held
3,685
Last filed at
Feb 28, 2020
Confidence Score
50.0
2025Q4
Confidence Score History
2019Q3 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Aug 18, 2025 Aug 19, 2025 ALNYLAM PHARMACEUTICALS, INC. Director Sell 3.8 -11,250 -35.10% ✓ $5.1M
May 15, 2025 May 19, 2025 ALNYLAM PHARMACEUTICALS, INC. Director Sell 5.0 -11,250 -35.10% ✓ $3.1M
Dec 27, 2023 Dec 29, 2023 ALNYLAM PHARMACEUTICALS, INC. Director Sell 3.8 -30,000 -59.97% ✓ $5.9M
Aug 2, 2023 Aug 4, 2023 ALNYLAM PHARMACEUTICALS, INC. Director Sell 37.5 -6,448 -24.35% ✗ $1.2M
Dec 4, 2019 Jun 9, 2020 BRISTOL MYERS SQUIBB CO Director Buy 67.5 +88 0.97% ✗ $5.2K
Sep 9, 2019 Sep 9, 2019 Sarepta Therapeutics, Inc. Director Buy 95.0 +2,000 39.60% ✗ $173.5K
Mar 9, 2016 Mar 10, 2016 ALNYLAM PHARMACEUTICALS, INC. Director Buy 95.0 +2,000 100.00% ✗ $116.7K
Aug 17, 2015 Aug 18, 2015 abrdn World Healthcare Fund Director Buy 95.0 +10,917 100.00% ✗ $200.3K
May 12, 2015 May 13, 2015 ALNYLAM PHARMACEUTICALS, INC. Director Buy 95.0 +2,000 100.00% ✗ $224.3K
Jul 28, 2014 Jul 29, 2014 abrdn Healthcare Opportunities Fund Director Buy 95.0 +5,000 100.00% ✗ $100K
Mar 9, 2012 Mar 12, 2012 abrdn Healthcare Investors Director Buy 91.3 +650 100.00% ✗ $10.3K
Mar 9, 2012 Mar 12, 2012 abrdn Life Sciences Investors Director Buy 91.3 +800 100.00% ✗ $10.6K